CD274 and neoplasm: There is growing literature on the significance of macrophage and lymphocyte PD-L1 positivity for predicting treatment response, highlighting the need to differentiate PD-L1 positivity in tumor cells versus tumor associated immune cells (i.e., macrophages and lymphocytes in the tumor compartment)8,9.